BRPI0514524A - nanopartìculas e processo para sua fabricação - Google Patents

nanopartìculas e processo para sua fabricação

Info

Publication number
BRPI0514524A
BRPI0514524A BRPI0514524-4A BRPI0514524A BRPI0514524A BR PI0514524 A BRPI0514524 A BR PI0514524A BR PI0514524 A BRPI0514524 A BR PI0514524A BR PI0514524 A BRPI0514524 A BR PI0514524A
Authority
BR
Brazil
Prior art keywords
nanoparticles
gelatin
maximum
manufacture
production
Prior art date
Application number
BRPI0514524-4A
Other languages
English (en)
Inventor
Michael Ahlers
Conrad Coester
Klaus Zwiorek
Jan Zillies
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of BRPI0514524A publication Critical patent/BRPI0514524A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

NANOPARTìCULAS E PROCESSO PARA SUA FABRICAçãO. Refere-se a nanopartículas biodegradáveis à disposição, que asseguram um transporte uniforme e definível de substância ativa e indicar simultaneamente um processo adequado para a produção dessas nanopartículas, propõe-se, que as nanopartículas consistam essencialmente em um gel de gelatina aquoso, em que o diâmetro médio das nanopartículas importe no máximo em 350 nm, o índice de polidispersidade das nanopartículas seja inferior ou igual a 0,15 e onde se utilize como material de partida para o processo de produção, uma gelatina, cuja fração de gelatina com um peso molecular abaixo de 65 kDa, em relação a toda a gelatina, importe no máximo em 40% em peso.
BRPI0514524-4A 2004-08-20 2005-08-18 nanopartìculas e processo para sua fabricação BRPI0514524A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004041340A DE102004041340A1 (de) 2004-08-20 2004-08-20 Nanopartikel und Verfahren zu deren Herstellung
PCT/EP2005/008954 WO2006021367A1 (de) 2004-08-20 2005-08-18 Nanopartikel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
BRPI0514524A true BRPI0514524A (pt) 2008-06-10

Family

ID=35276582

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514524-4A BRPI0514524A (pt) 2004-08-20 2005-08-18 nanopartìculas e processo para sua fabricação

Country Status (14)

Country Link
US (1) US20080003292A1 (pt)
EP (1) EP1793810A1 (pt)
JP (1) JP2008510688A (pt)
KR (1) KR20070046850A (pt)
CN (1) CN1988892A (pt)
AU (1) AU2005276675A1 (pt)
BR (1) BRPI0514524A (pt)
CA (1) CA2575407A1 (pt)
DE (1) DE102004041340A1 (pt)
IL (1) IL180954A0 (pt)
MX (1) MX2007001996A (pt)
NO (1) NO20071458L (pt)
NZ (1) NZ551326A (pt)
WO (1) WO2006021367A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006325225B2 (en) 2005-12-14 2013-07-04 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
JP5147699B2 (ja) * 2005-12-20 2013-02-20 富士フイルム株式会社 タンパク質ナノ粒子およびその使用
JP2007224012A (ja) * 2006-01-30 2007-09-06 Fujifilm Corp 酵素架橋したタンパク質ナノ粒子
SG172696A1 (en) 2006-06-12 2011-07-28 Cytos Biotechnology Ag Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
JP2008001764A (ja) * 2006-06-21 2008-01-10 Gunma Univ タンパク質からなる粒子状成形体の製造方法及び、該方法により得られたタンパク質からなる粒子状成形体
JP5275561B2 (ja) * 2006-10-30 2013-08-28 富士フイルム株式会社 水分散可能なナノ粒子
EP1970077B1 (en) * 2007-03-16 2009-10-14 National Chi Nan University A biogradable material with nanopores and electric conductivity and the fabricating method thereof
JP2008260705A (ja) * 2007-04-11 2008-10-30 Fujifilm Corp 注射用組成物
JP2008297241A (ja) * 2007-05-31 2008-12-11 Fujifilm Corp ニキビ用皮膚外用剤
DE102007041625A1 (de) * 2007-09-03 2009-03-05 Sinn, Hannsjörg, Dr. Neue Gelatine-Wirkstoff-Konjugate
KR101913874B1 (ko) 2010-11-10 2018-10-31 인리젠 장기 확대를 위한 주사가능 제제
EP2540287A1 (en) * 2011-07-01 2013-01-02 FutureChemistry Continuous flow production of gelatin nanoparticles
DE102011052396A1 (de) * 2011-08-04 2013-02-07 Gelita Ag Verfahren zur Herstellung einer stabilen Dispersion von Nanopartikeln, hergestellte Dispersion und deren Verwendung
WO2017110745A1 (ja) * 2015-12-25 2017-06-29 コニカミノルタ株式会社 ゼラチン粒子、ゼラチン粒子の製造方法、ゼラチン粒子内包細胞、およびゼラチン粒子内包細胞の製造方法
CA3010995A1 (en) 2016-01-25 2017-08-03 Suntory Holdings Limited Capsule containing functional substance and method for manufacturing said capsule
CN107376008B (zh) 2017-07-21 2019-10-22 深圳华诺生物科技有限公司 一种无机纳米颗粒-明胶核壳结构复合材料颗粒的制备方法
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
EP3954399B1 (en) * 2020-04-09 2023-11-15 Plmicromed Co., Ltd. Microbeads for embolization and composition for treating proliferative diseases
KR102386631B1 (ko) * 2020-04-09 2022-04-15 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
KR102645182B1 (ko) * 2021-08-23 2024-03-07 전남대학교산학협력단 젤라틴 가교입자의 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140195C2 (de) * 1991-12-05 1994-10-27 Alfatec Pharma Gmbh Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung
US5932245A (en) * 1991-12-05 1999-08-03 Alfatec Pharma Gmbh Gelatin or collagen hydrolysate containing drug formulation that provides for immediate release of nanoparticle drug compounds
DE19838189A1 (de) * 1998-08-24 2000-03-02 Basf Ag Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung
DE60024791T2 (de) * 1999-04-08 2006-07-06 The Johns Hopkins University Antigen-spezifische induktion der peripheren immuntoleranz
DE60334924D1 (de) * 2002-09-11 2010-12-23 Elan Pharma Int Ltd Anoteilchengrösse
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung

Also Published As

Publication number Publication date
KR20070046850A (ko) 2007-05-03
AU2005276675A1 (en) 2006-03-02
IL180954A0 (en) 2007-07-04
DE102004041340A1 (de) 2006-02-23
EP1793810A1 (de) 2007-06-13
MX2007001996A (es) 2007-05-10
NZ551326A (en) 2010-04-30
CN1988892A (zh) 2007-06-27
US20080003292A1 (en) 2008-01-03
CA2575407A1 (en) 2006-03-02
NO20071458L (no) 2007-03-19
JP2008510688A (ja) 2008-04-10
WO2006021367A1 (de) 2006-03-02

Similar Documents

Publication Publication Date Title
BRPI0514524A (pt) nanopartìculas e processo para sua fabricação
Tamer et al. MitoQ loaded chitosan-hyaluronan composite membranes for wound healing
Drabczyk et al. Physicochemical investigations of chitosan-based hydrogels containing aloe vera designed for biomedical use
Kulka et al. Chitosan based materials in cosmetic applications: A review
Lustosa et al. In situ synthesis of silver nanoparticles in a hydrogel of carboxymethyl cellulose with phthalated-cashew gum as a promising antibacterial and healing agent
Iacob et al. Preparation, characterization and wound healing effects of new membranes based on chitosan, hyaluronic acid and arginine derivatives
Bhowmik et al. Reinforcement of gelatin-based nanofilled polymer biocomposite by crystalline cellulose from cotton for advanced wound dressing applications
Tamayo Marín et al. Biocompatible and antimicrobial electrospun membranes based on nanocomposites of chitosan/poly (vinyl alcohol)/graphene oxide
Zarandona et al. 3D printed chitosan-pectin hydrogels: from rheological characterization to scaffold development and assessment
Ng et al. Monitoring the degradation of collagen hydrogels by collagenase clostridium histolyticum
Spiridon et al. Development and performance of bioactive compounds-loaded cellulose/collagen/polyurethane materials
Morganti et al. Green nanotechnology serving the bioeconomy: Natural beauty masks to save the environment
Bonadies et al. Ph-responsive resveratrol-loaded electrospun membranes for the prevention of implant-associated infections
BRPI0311700B8 (pt) processo para a produção de uma preparação em forma de película e preparação em forma de película
Salesa et al. Carbon nanofibers versus silver nanoparticles: Time-dependent cytotoxicity, proliferation, and gene expression
BR112015028278A2 (pt) processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos
Huang et al. Enhancement of cell adhesion, cell growth, wound healing, and oxidative protection by gelatins extracted from extrusion-pretreated tilapia (Oreochromis sp.) fish scale
Ferreira et al. Multifunctional gelatin/chitosan electrospun wound dressing dopped with Undaria pinnatifida phlorotannin-enriched extract for skin regeneration
Antoniel et al. Tendon extracellular matrix remodeling and defective cell polarization in the presence of collagen VI mutations
Shagdarova et al. Collagen/chitosan gels cross-linked with genipin for wound healing in mice with induced diabetes
Vargas-Alfredo et al. Synthesis and modification of gelatin methacryloyl (GelMA) with antibacterial quaternary groups and its potential for periodontal applications
Shimojo et al. Association of platelet-rich plasma and auto-crosslinked hyaluronic acid microparticles: Approach for orthopedic application
Parın et al. Development of PVA–psyllium husk meshes via emulsion electrospinning: Preparation, characterization, and antibacterial activity
Sharma et al. Development and evaluation of rifampicin loaded alginate–gelatin biocomposite microfibers
Chuysinuan et al. Turmeric herb extract-incorporated biopolymer dressings with beneficial antibacterial, antioxidant and anti-inflammatory properties for wound healing

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2138 DE 27/12/2011.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 9/48; A61K 9/14; A61K 9/50; A61K 9/51; A61K 47/48.

Ipc: A61K 9/51 (2006.01), B82Y 5/00 (2011.01)

Ipc: A61K 9/51 (2006.01), B82Y 5/00 (2011.01)